IXI Share PerformanceMore
|52 week high||44.000 05/12/16|
|52 week low||22.200 05/04/17|
|52 week change||4.000 (14.04%)|
|4 week volume||56,241 27/10/17|
Latest News« previous» nextMore
16/11/2017 - 08:20 StockMarketWire
IXICO has signed a new contract with another leading biopharmaceutical company to support the use of wrist worn activ...
16/11/2017 - 07:00 RNS
RNS Number: 6394W IXICO plc 16 November 2017 16 November 2017 IXICO plc ("IXICO" or the "Company") IXICO signs its first contract with a new biopharma customer to deploy biosensors in a late stage clinical trial for a psychiatric disorder Further expansion of IXICO's biopharma customer base and wearable biosensor technology IXICO plc (AIM: IXI), the dig...
19/10/2017 - 13:03 StockMarketWire
IXICO has reported revenue for the year ended 30 September of 3.7m (2016: 3.1m). The Company said the 0.6m increase over...
19/10/2017 - 09:14 RNS
RNS Number: 0775U IXICO plc 19 October 2017 19 October 2017 IXICO plc ("IXICO" or the "Company") Pre-Close Trading Update Double-digit revenue growth Three new contracts signed in September, including first wearables contract IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today provides the following pre-close trading update...
04/10/2017 - 06:49 StockMarketWire
IXICO has signed a new contract, with a top 15 global pharmaceutical company, utilising wrist worn activity sensors ('wear...
04/10/2017 - 06:00 RNS
RNS Number: 6071S IXICO plc 04 October 2017 4 October 2017 IXICO plc ("IXICO" or the "Company") IXICO signs new contract to deploy biosensors in a Phase II neurological clinical trial First commercial contract using IXICO's wearable biosensor technology IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has si...
28/09/2017 - 06:00 RNS
RNS Number: 0234S IXICO plc 28 September 2017 28 th September 2017 IXICO plc ("IXICO" or the "Company") New contract in Huntington's disease with US-based pharmaceutical company IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has signed a new contract with a customer for its technology enabled imag...
25/09/2017 - 07:21 StockMarketWire
IXICO, the digital technologies company serving neuroscience, has signed a new contract with a North American based bio...
|Dividend yield||0 %|
Latest discussion posts More
“Very promising trading statement today........ 'double digit revenue growth'.. 'strong performance'.. 'ahead of expectations'.. '3 new contracts including first wearables'.. ...”▼
“Well, after the news this morning this all but disappeared down the toilet, but then the buyers moved in...... has some support after all. Been an interesting few weeks.”▼
“It would be nice to see 60p by the end of the week, now that it's got a little momentum. Pi”▼
Codes & Symbols
|Symbols||IXI, LSE:IXI, IXI.L, IXI:LN, LON:IXI, XLON:IXI|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment